ERAL1 and breast cancer: We examined the miTranscriptome data of 839 breast cancer tissues from the TCGA database [34] and found that DSCAM-AS1 expression is significantly higher in ERα+ versus ERα- cases (p-value < 0.00001) (Figure 4D).